After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricingJune 16, 2023Business of MedicineRheumatologyGastroenterologyDermatology
The enemy of carcinogenic fumes is my friendly begoniaJune 8, 2023LOTMEMixed TopicsBusiness of MedicineGastroenterologyPulmonology
APA launches online eating disorder assessment toolJune 2, 2023Mental HealthGastroenterologyAdolescent Medicine
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitisJune 1, 2023DermatologyRheumatologyAsthmaGastroenterology
Multiple successive biologic to biosimilar switches deemed safe and effectiveMay 31, 2023GastroenterologyRheumatologyMixed Topics
AxSpA remission on TNFi seen in half of patients with comorbid IBDMay 25, 2023GastroenterologyRheumatology
FDA approves Yuflyma as ninth adalimumab biosimilarMay 24, 2023Rare DiseasesDermatologyGastroenterologyRheumatology
FDA approves autoinjector pen for Humira biosimilar, CyltezoMay 24, 2023DermatologyGastroenterologyRheumatologyRare Diseases
